Home・Aandelen Lijst・Quanterix Corp

Quanterix Corp

Gesloten

SectorGezondheidszorg

2.93 12.26

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

2.46

Max

2.93

Belangrijke statistieken
By Trading Economics
Inkomsten	-31M -49M
Verkoop	-3.5M 33M
EPS	-0.45
Winstmarge	-148.708
Werknemers	450
EBITDA	-38M -49M

Aanbevelingen
By TipRanks
Aanbevelingen	Neutraal
12 Maanden Prognose	+33.59% upside

Dividenden
By Acuity
Volgende Winsten	9 nov 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	-45M 114M
Vorige openingsprijs	-9.33
Vorige sluitingsprijs	2.93

Quanterix Corp Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

12 aug 2026, 23:01 UTC

Quanterix Corp. shares are trading roughly flat in after-market hours. The stock has seen a significant decline over the past month, remaining below its 20-day moving average.

11 aug 2026, 22:51 UTC

Quanterix Corp shares are lower in after-market hours, continuing a decline from Tuesday's close amid broader market pressure and rising crude oil prices.

10 aug 2026, 19:51 UTC

Event

Social Media

News

Quanterix Corp reported a wider second-quarter loss and lowered full-year revenue guidance, leading to a significant decline in shares amid investor concerns.

7 aug 2026, 19:16 UTC

Quanterix Corp shares are higher today, continuing a trend with three consecutive sessions of gains since Thursday. The stock is trading above its 20-day moving average.

5 aug 2026, 19:23 UTC

Quanterix Corp shares are higher, supported by a broader rise in the Life Sciences Tools & Services sector. The stock remains below its 20-day moving average.

3 aug 2026, 19:26 UTC

Quanterix Corp shares are higher today, tracking broader market gains amid rising confidence in tech stocks and falling energy prices.

31 jul 2026, 19:46 UTC

Quanterix Corp shares are higher today, reflecting a modest gain since Thursday's close. The stock is near the lower end of its one-month range.

30 jul 2026, 19:59 UTC

Quanterix Corp is trading higher amid a broader recovery in tech shares. The asset has shown notable volatility, pulling back from earlier session highs.

29 jul 2026, 19:43 UTC

Macro Event

Quanterix Corp's shares are lower today amid broader market declines, reflecting heightened volatility following the Federal Reserve's decision to maintain interest rates.

28 jul 2026, 20:06 UTC

Quanterix Corp shares are declining amid broader market weakness, with the Nikkei 225 dropping significantly due to concerns over AI spending and semiconductor competition.

27 jul 2026, 16:06 UTC

Quanterix Corp shares are higher today, following a strong opening. No specific news was identified to explain the price movement.

24 jul 2026, 19:53 UTC

Quanterix Corp shares are lower today, continuing a decline since Thursday amid broader market uncertainty from oil volatility and new U.S. tariffs.

22 jul 2026, 19:36 UTC

Quanterix Corp shares are lower in Wednesday's session, continuing a decline since Tuesday's close amid rising crude oil prices and market concerns.

21 jul 2026, 21:26 UTC

Quanterix Corp shares are higher in after-market hours, reflecting positive trading momentum. Broader market strength may be influencing sentiment following the close.

20 jul 2026, 19:46 UTC

Quanterix Corp shares are higher today amid positive market sentiment and a notable rise in the Hang Seng 50 Index, despite no specific company news.

Peer Vergelijking

Prijswijziging

Quanterix Corp Prognose

Koersdoel

By TipRanks

33.59% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 3.5 USD 33.59%

Hoogste 4 USD

Laagste 3 USD

Gebaseerd op 2 Wall Street-analisten die 12-maands prijsdoelen bieden voor Quanterix Corp - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Neutraal

2 ratings

Buy

Hold

Sell

Gebaseerd op 2 analisten die aandelenratings hebben gegeven aan Quanterix Corp - Dist in de afgelopen 3 maanden.

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Quanterix Corp

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, it offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.